The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626001185358
Ethics application status
Help: Ethics application status
Approved
Date submitted
Help: Date submitted
8/09/2026
Date registered
Help: Date registered
23/09/2026
Date last updated
Help: Date last updated
23/09/2026
Date data sharing statement initially provided
Help: Data sharing statement date
23/09/2026
Type of registration
Help: Type of registration
Prospectively registered

Titles & IDs
Public title
Comparison of passive heating modalities designed to promote acute exercise performance in heart failure
Scientific title
Comparison of lower-limb passive heating modalities designed to promote acute walk distance during the incremental shuttle walk test in heart failure
Additional trial identifiers [1] 318383 0
Nil
Universal Trial Number (UTN)
Trial acronym
Related trial records

Health condition
Health condition(s) studied:
heart failure 343524 0
Condition category
Condition code
Physical Medicine / Rehabilitation 339628 339628 0 0
Other physical medicine / rehabilitation
Cardiovascular 339629 339629 0 0
Coronary heart disease

Intervention/exposure
Study type
Interventional
Description of the intervention or exposure
This is a randomised crossover study. Participants will undertake three separate experimental visits. On separate days, in randomised order, participants will receive 45 minutes of exposure to each of three distinct passive lower-limb heating modalities: (i) knee-down water immersion (42°C), (ii) hot-water perfused trousers, and (iii) infrared leg heating devices and control condition (iv) where no heating intervention is applied. All interventions will be administered (face-to-face) at Griffith University, Gold Coast Campus by the lead study investigator. A minimum of 5 days between experimental exposures will be mandated to ensure adequate washout between conditions.
Intervention code [1] 335275 0
Rehabilitation
Description of the comparator or control
A fourth trial condition will be completed where participants do not receive any heating intervention. While no intervention will be undertaken, participants will following the same protocols and procedures as intervention visits (physiological monitoring, seated for a duration of 45 min), as well as undertaking the endurance shuttle walk test following the seated period.
Control group
Active

Outcomes
Primary outcome [1] 346802 0
Endurance shuttle walk test distance
Timepoint [1] 346802 0
Post acute heating intervention
Secondary outcome [1] 467631 0
Femoral artery blood flow
Timepoint [1] 467631 0
Pre-, during- and post- heating intervention
Secondary outcome [2] 467632 0
Heart rate
Timepoint [2] 467632 0
Pre-, during- and post-intervention
Secondary outcome [3] 467633 0
cardiac output
Timepoint [3] 467633 0
pre- during- and post-internvetion
Secondary outcome [4] 467634 0
stroke volume
Timepoint [4] 467634 0
pre-, during- and post-intervention

Eligibility
Key inclusion criteria
Confirmed diagnosis of heart failure with reduced ejection fraction (HFrEF) referred via cardiac rehabilitation pathways
New York Heart Association class I-II
Aged >18 years
Male or female (recruitment will aim to enrol a meaningful number of female participants, given the male-predominance of HFrEF)
No exacerbation of heart failure-related symptoms or change in medications within the preceding 3 months
Free from unstable angina, recent myocardial infarction, or severe valvular disease
No skin conditions precluding limb immersion
Meets standard exercise testing eligibility (no absolute contraindications to exercise testing, per standard increased-risk criteria)
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Healthy volunteers
No
Key exclusion criteria
NYHA class III or IV
Heart failure with preserved ejection fraction (HFpEF)
Younger than 18 years
Exacerbation of heart failure symptoms or change in medications within the preceding 3 months
Unstable angina, recent myocardial infarction, or severe valvular disease
Skin conditions that would preclude limb immersion
Meets standard exercise testing contraindications or increased-risk criteria (e.g., unstable cardiovascular status, uncontrolled arrhythmia, decompensated heart failure, severe or symptomatic aortic stenosis, acute systemic illness, uncontrolled hypertension, recent embolism, or thrombophlebitis)

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Allocation not concealed
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Simple randomisation key in Microsoft Excel.
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?
The people receiving the treatment/s
The people administering the treatment/s
The people assessing the outcomes
The people analysing the results/data
Intervention assignment
Crossover
Other design features
Phase
Not Applicable
Type of endpoint/s
Safety/efficacy
Statistical methods / analysis
A sample size of n=25 provides >80% power to detect clinically meaningful differences in femoral blood flow and exercise endurance between heating modalities, based on effect sizes derived from our previously published work in HF, accounting for an anticipated 10% dropout rate. This sample size also supports meaningful enrolment of females (approximately 8 participants, based on the expected 2:1 male-predominance of HFrEF) for descriptive and covariate analysis of sex; the study is not independently powered to test a formal sex × condition interaction.

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
NSW,QLD

Funding & Sponsors
Funding source category [1] 322954 0
Charities/Societies/Foundations
Name [1] 322954 0
The Common Good
Country [1] 322954 0
Australia
Primary sponsor type
University
Name
Griffith University
Address
Country
Australia
Secondary sponsor category [1] 325880 0
None
Name [1] 325880 0
Address [1] 325880 0
Country [1] 325880 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 321370 0
Griffith University Human Research Ethics Committee
Ethics committee address [1] 321370 0
Ethics committee country [1] 321370 0
Australia
Date submitted for ethics approval [1] 321370 0
31/07/2026
Approval date [1] 321370 0
11/08/2026
Ethics approval number [1] 321370 0

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 153518 0
Dr Fergus O'Connor
Address 153518 0
Griffith University, 1 Parklands Dve, Southport, QLD, 4211
Country 153518 0
Australia
Phone 153518 0
+61 412032266
Fax 153518 0
Email 153518 0
Contact person for public queries
Name 153519 0
Fergus O'Connor
Address 153519 0
Griffith University, 1 Parklands Dve, Southport, QLD, 4211
Country 153519 0
Australia
Phone 153519 0
+61 412032266
Fax 153519 0
Email 153519 0
Contact person for scientific queries
Name 153520 0
Fergus O'Connor
Address 153520 0
Griffith University, 1 Parklands Dve, Southport, QLD, 4211
Country 153520 0
Australia
Phone 153520 0
+61 412032266
Fax 153520 0
Email 153520 0

Data sharing statement
Will the study consider sharing individual participant data?
Yes
Will there be any conditions when requesting access to individual participant data?
Persons/groups eligible to request access:
• Researchers
Conditions for requesting access:
• Yes, conditions apply:
• Requires review on a case-by-case basis by the trial custodian, sponsor or data sharing committee
• Requires a scientifically sound proposal or protocol
• Requires approval by an ethics committee
• Requires a data sharing agreement between data requester and trial custodian or sponsor
What individual participant data might be shared?
• All de-identified individual participant data
What types of analyses could be done with individual participant data?
• Any type of analysis (i.e. no restrictions on data re-use)
When can requests for individual participant data be made (start and end dates)?
From:
At the end of the study
To:
No end date
Where can requests to access individual participant data be made, or data be obtained directly?
• Email of trial custodian, sponsor or committee: direct contact to the study lead; Dr Fergus O'Connor, [email protected]

Are there extra considerations when requesting access to individual participant data?
No


What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.